游离脂肪酸受体1
炎症
受体
炎症性肠病
短链脂肪酸
医学
药理学
化学
免疫学
内科学
生物化学
疾病
发酵
丁酸盐
兴奋剂
作者
Adrian Bartoszek,Ee Von Moo,Agata Binienda,Adam Fabisiak,Julia Krajewska,Paula Mosińska,Karolina Niewinna,Aleksandra Tarasiuk,Kirill A. Martemyanov,Maciej Sałaga,Jakub Fichna
标识
DOI:10.1016/j.phrs.2019.104604
摘要
Family of Free Fatty Acid Receptors (FFARs), specific G protein-coupled receptors comprises of four members: FFAR1-4, where each responds to different chain length of fatty acids (FAs). Over the years, FFARs have become attractive pharmacological targets in the treatment of type 2 diabetes, metabolic syndrome, cardiovascular diseases and asthma; recent studies also point to their role in inflammation. It is now well-established that activation of FFAR1 and FFAR4 by long and medium chain FAs may lead to reduction of inflammatory state; FFAR2 and FFAR3 are activated by short chain FAs, but only FFAR2 was shown to alleviate inflammation, mostly by neutrophil inhibition. All FFARs have thus been proposed as targets in inflammatory bowel diseases (IBD). Here we discuss current knowledge and future directions in FFAR research related to IBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI